Latest News

  • Review shows: EGb 761® optimizes standards of life for tinnitus patients!

    Read more

Image Film

Bild Modem DSL/LAN

Download

Icon: pdf
Imagebrochure (1.8 MB)

Dr. Willmar Schwabe Group
 
   
Turnover 2012 € 610 Mill.
 
International Share 64 %
 
Research & Development Expenditure 2012 World-wide € 27 Mill. (Group-wide)

Employees World-wide Approx. 3500 (Group-wide)
 
Dr. Willmar Schwabe GmbH & Co. KG
 
Location Willmar-Schwabe-Str. 4
76227 KARLSRUHE
GERMANY
 
Executive Board Dr. Dirk Reischig (Chairman)
Prof. Dr. Michael Habs
Dr. Rainer Oschmann
 
Employees 702 
Product Range Phytomedicines
 
Research & Development Focus Plant-based Special Extracts
 
Dr. Willmar Schwabe World-wide
 

Austria:
Austroplant Arzneimittel
Dr. Peithner GmbH & Co.

Belgium:
VSM Belgium

Canada:
Schwabe North America                                        

Czech Republic:
Schwabe Czech Republic s.r.o.

Germany:
Deutsche Homöopathie-Union
Farmasan Arzneimittel
ISO-Arzneimittel
Schwabe Extracta
Spitzner Arzneimittel
Bioplanta Arzneimittel

Hungary:
Schwabe Hungary kft.

India:
Dr. Willmar Schwabe India

Italy:
Loacker Remedia

Mexico:
Farmasa Schwabe
Schwabe México

Netherlands:
VSM Geneesmiddelen

Russia:
Representative Office

Singapore:
Schwabe Pharma Asia Pacific

Slovakia:
Schwabe Slovakia sro.

Spain:
DHU Ibérica

Switzerland:
Schwabe Pharma
Omida
Piniol

United Kingdom:
Schwabe Pharma UK

USA:
Schwabe North America
Date: April 2013
Contact Address

Dr. Willmar Schwabe GmbH & Co. KG
Willmar-Schwabe-Str. 4
76227 KARLSRUHE
GERMANY

Phone: +49 (0) 721 4005 – 101
Fax: +49 (0) 721 4005 – 202